BullFrog AI (BFRG) announced that its collaboration with Sygnature Discovery specializing in drug discovery, has entered the commercial phase. With the formal sales kickoff on September 12, BullFrog AI’s proprietary BullFrog Data Networks platform is now actively being introduced to Sygnature’s global client base, representing a revenue opportunity estimated at $15-$30 million through 2028.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFRG:
